Development asset linked to Secura Bio in public FDA and regional records.
pharma
Secura Bio
Secura Bio Limited
Secura Bio drug portfolio — 7 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Berkeley Heights, USA HQ
2019 Founded
55 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Berkeley Heights, USA
- Founded
- 2019
- Employees
- 55
- Programs
- 1
- Drugs
- 7
- Patents
- 0
Secura Bio pipeline
Portfolio lens on 7 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Secura Bio drug portfolio — 7 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Secura Bio in public FDA and regional records.
-
Development asset linked to Secura Bio in public FDA and regional records.
-
US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
-
duvelisib
Antineoplastic and immunomodulating agents (L01)US regulatory status: approved. Mechanism: PI3-kinase p110-gamma subunit inhibitor.
- Mechanism
- PI3-kinase p110-gamma subunit inhibitor
-
US regulatory status: approved. Mechanism: DNA polymerase (alpha/delta/epsilon) inhibitor.
- Mechanism
- DNA polymerase (alpha/delta/epsilon) inhibitor
-
Development asset linked to Secura Bio in public FDA and regional records.